ThioBridge Tribody Drug Conjugates (Biotecnol/PolyTherics)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameThioBridge Tribody Drug Conjugates (Biotecnol/PolyTherics)
Drug Alias NameThioBridge brentuximab MMAEThioBridge trastuzumab MMAE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzena LtdBiotecnol Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A